Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Clinical trial NCT02853305 · COMPLETED
Trial details
- NCT number
- NCT02853305
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-15
- Primary completion
- 2020-04-29
- Enrollment
- 1010
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.